Title |
Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
|
---|---|
Published in |
PLOS ONE, April 2012
|
DOI | 10.1371/journal.pone.0033672 |
Pubmed ID | |
Authors |
Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E. Mujica Mota, A. Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G. Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M. Gibb, Charles F. Gilks |
Abstract |
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | <1% |
Sweden | 1 | <1% |
Germany | 1 | <1% |
Unknown | 101 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 19% |
Student > Master | 19 | 18% |
Student > Ph. D. Student | 16 | 15% |
Unspecified | 8 | 8% |
Student > Postgraduate | 7 | 7% |
Other | 21 | 20% |
Unknown | 13 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 24% |
Nursing and Health Professions | 10 | 10% |
Unspecified | 8 | 8% |
Agricultural and Biological Sciences | 7 | 7% |
Social Sciences | 7 | 7% |
Other | 26 | 25% |
Unknown | 21 | 20% |